37.65
price up icon3.49%   1.27
after-market After Hours: 37.65
loading

Immunovant Inc Stock (IMVT) Forecast

The Immunovant Inc (IMVT) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $42.47, representing a +12.80% increase from the current price of $37.65. The highest analyst price target is $43.30, and the lowest is $41.64.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month IMVT Price Target
Average 43.45 (+15.40% Upside)
loading

Is Immunovant Inc (IMVT) A Buy Now?

Oscillators
Name Value Action
RSI(14) 31.80 Neutral
STOCH(9,6) 10.28 Buy
STOCHRSI(14) 8.7734 Buy
MACD(12,26) -0.6788 Sell
ADX(14) 19.36 Neutral
William %R -97.67 Buy
CCI(14) -83.64 Neutral
Buy: 3 Sell: 1 Neutral: 3
Summary: Neutral
Moving Averages
Period Simple Exponential
MA10
39.36
Sell
39.41
Sell
MA20
41.58
Sell
40.28
Sell
MA50
40.44
Sell
39.53
Sell
MA100
36.11
Buy
36.61
Buy
MA200
30.87
Buy
31.60
Buy
Buy: 4 Sell: 6 Neutral: 0
Summary: Sell
According to our latest analysis, IMVT could be considered a Neutral, with 17 technical analysis indicators signaling 7 Buy signals, 7 signaling Sell signals and 3 Neutral signals. This suggests that investors should exercise caution when entering new positions on IMVT, as the market is likely to remain volatile in the near term.
  1. RSI (Relative Strength Index): The RSI(14) value of 31.8 indicates that IMVT is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 10.28 indicates that IMVT is oversold. This indicates that IMVT price is at or near the lowest level over a specified lookback period.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 8.7734 indicates that IMVT is oversold. This suggests that IMVT price is at or near the lowest level relative to its recent price history.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 19.36 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -83.64 indicates that IMVT is still oversold but not to an extreme extent.

Long-term IMVT price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Immunovant Inc financial reports and earnings history, Immunovant Inc (IMVT) stock could reach $49.69 by 2030, $166.32 by 2040 and $212.31 by 2050. See the projected annual prices until 2050 of the Immunovant Inc stock below:

  • Immunovant Inc (IMVT) is expected to reach an average price of $137.53 in 2035, with a high prediction of $147.22 and a low estimate of $137.49. This indicates an $265.30% rise from the last recorded price of $37.65.
  • Immunovant Inc (IMVT) stock is projected to chart a bullish course in 2040, with an average price target of $164.28, representing an $336.33% surge from its current level. The forecast ranges from a conservative $162.62 to a sky-high $166.32.
  • Our analysts predict Immunovant Inc (IMVT) to jump 421.13% by 2045, soaring from $194.62 to an average price of $196.20, potentially reaching $196.94. While $194.62 is the low estimate, the potential upside is significant.
  • Immunovant Inc (IMVT) stock is expected to climb by 2050, reaching an average of $212.05, a $463.22% jump from its current level. However, a wide range of estimates exists, with high and low targets of $212.31 and $210.46, respectively, highlighting the market's uncertainty.

Immunovant Inc Stock (IMVT) Year by Year Forecast

Immunovant Inc Stock (IMVT) Price Forecast for 2026

The predicted value for Immunovant Inc (IMVT) in 2026 is set at an average of $61.41. Estimates vary from a peak of $82.77 to a trough of $40.05, indicating an +63.11% surge from the present price of $37.65.
Month Average Low High Change from today's price
October, 2026 $42.71 $41.64 $43.30 +13.45%
November, 2026 $43.42 $42.42 $43.77 +15.31%
December, 2026 $43.76 $42.82 $44.35 +16.22%

Immunovant Inc Stock (IMVT) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Immunovant Inc (IMVT) is $44.97, with a high forecast of $47.54 and a low forecast of $42.39. This indicates an +19.44% increase from the last price of $37.65.
Month Average Low High Change from today's price
January, 2027 $43.36 $42.99 $44.39 +15.16%
February, 2027 $44.10 $43.15 $44.26 +17.13%
March, 2027 $43.46 $43.03 $45.25 +15.43%
April, 2027 $42.71 $42.49 $44.04 +13.45%
May, 2027 $42.84 $42.39 $43.42 +13.80%
June, 2027 $43.35 $42.80 $44.41 +15.13%
July, 2027 $43.16 $43.10 $43.69 +14.63%
August, 2027 $43.51 $42.58 $43.59 +15.56%
September, 2027 $43.77 $42.77 $44.31 +16.26%
October, 2027 $44.82 $43.88 $45.20 +19.05%
November, 2027 $47.04 $44.49 $47.18 +24.95%
December, 2027 $46.31 $46.11 $47.54 +23.01%

Immunovant Inc Stock (IMVT) Price Forecast for 2028

In 2028, Immunovant Inc (IMVT) is projected to reach an average price of $59.20, with a high projection of $72.46 and a low estimate of $45.94. This indicates an +57.23% rise from the last price of $37.65.
Month Average Low High Change from today's price
January, 2028 $51.11 $45.94 $51.93 +35.74%
February, 2028 $54.45 $50.92 $54.82 +44.61%
March, 2028 $57.68 $54.06 $57.71 +53.20%
April, 2028 $61.23 $57.25 $61.38 +62.63%
May, 2028 $61.85 $58.04 $63.96 +64.28%
June, 2028 $61.68 $59.51 $63.61 +63.83%
July, 2028 $60.54 $59.90 $62.80 +60.81%
August, 2028 $61.15 $59.50 $62.12 +62.41%
September, 2028 $67.34 $61.16 $67.80 +78.85%
October, 2028 $67.91 $66.83 $70.43 +80.37%
November, 2028 $67.95 $65.25 $68.80 +80.48%
December, 2028 $69.59 $68.59 $72.46 +84.84%

Immunovant Inc Stock (IMVT) Price Forecast for 2029

The 2029 price forecast for Immunovant Inc Stock (IMVT) is $71.75 on average, with a high prediction of $96.40 and a low estimate of $47.09. This represents an +90.56% increase from the previous price of $37.65.
Month Average Low High Change from today's price
January, 2029 $72.28 $66.75 $72.56 +91.99%
February, 2029 $87.17 $68.28 $92.97 +131.51%
March, 2029 $82.68 $81.48 $88.45 +119.59%
April, 2029 $83.56 $80.79 $85.65 +121.93%
May, 2029 $93.08 $81.82 $95.04 +147.22%
June, 2029 $93.18 $86.32 $96.40 +147.49%
July, 2029 $86.23 $86.19 $93.38 +129.04%
August, 2029 $87.20 $85.49 $91.33 +131.62%
September, 2029 $84.70 $81.85 $88.24 +124.95%
October, 2029 $80.43 $79.81 $84.91 +113.62%
November, 2029 $47.40 $47.09 $82.37 +25.90%
December, 2029 $48.37 $47.43 $48.40 +28.48%

Immunovant Inc Stock (IMVT) Price Forecast for 2030

Immunovant Inc Stock (IMVT) is expected to reach an average price of $64.16 in 2030, with a high forecast of $79.71 and a low forecast of $48.61. This signifies an +70.42% surge from the last price of $37.65.
Month Average Low High Change from today's price
January, 2030 $49.69 $48.61 $49.69 +31.97%
February, 2030 $50.77 $49.93 $50.80 +34.85%
March, 2030 $51.87 $51.01 $51.93 +37.78%
April, 2030 $52.85 $52.09 $52.86 +40.36%
May, 2030 $55.46 $53.07 $55.86 +47.30%
June, 2030 $60.46 $55.61 $62.25 +60.59%
July, 2030 $62.12 $60.27 $64.01 +64.98%
August, 2030 $63.17 $60.74 $64.81 +67.78%
September, 2030 $63.54 $55.83 $64.94 +68.75%
October, 2030 $67.73 $61.51 $68.54 +79.90%
November, 2030 $70.15 $67.19 $73.58 +86.31%
December, 2030 $78.14 $71.39 $79.71 +107.54%
$58.93
price up icon 0.79%
$123.98
price up icon 1.14%
$39.98
price up icon 1.04%
$245.51
price up icon 2.57%
ONC ONC
$353.46
price up icon 1.55%
$196.94
price up icon 0.52%
Cap:     |  Volume (24h):